RxDoctor Payments Data

Anna Rosengren-Hovee, MD

Infectious Disease · Chapel Hill, NCNPI 1427494467

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $1,823 of the $2,938 with a category attached, or 62.1%. Merck accounts for 67.9% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $2,051, more than ten times the $119 reported in 2019.

$2,938in general payments, 2019–2025

Across 52 payments — averaging $56.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$2K
  • Viiv Healthcare Company$536
  • Janssen Products, LP$235
  • Gilead$124
  • Theratechnologies Inc.$35
  • Johnson & Johnson$12
$650,361in research payments, 2019–2025

Across 16 payments — averaging $40,648 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$472K
  • Gilead$178K

What the payments were for

  • Travel & lodging$1,82362%
  • Food & beverage$88030%
  • Education$2358%

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,938 in reported general payments places this provider in the 75th percentile of 250 infectious disease providers in North Carolina.

See all infectious disease providers in North Carolina

Medicare billing

Part B allowed, 2024
$3,962
Medicare patients
23
Services billed
41

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other infectious disease in Chapel Hill

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →